PathAI (company)

PathAI (company)

PathAI is a Boston-based artificial intelligence company developing therapeutics and healthcare products.

PathAI, located in Boston, Massachusetts, is a medical technology company that runs a technical pathology program that can provide an efficient and more accurate diagnoses for patients and providers. Additionally, the software is currently working to further assist in research, drug development, global health solutions, and treatments.

PathAI has two primary missions for its AI product: help pathologists make more accurate diagnoses and better predict how patients will respond to a pathologist's recommended therapy based on the characteristics of patient tissue.

Timeline

November 14, 2019
PathAI Appoints biopharma executive and digital pathology leader Michael Montalto, Ph.D., as Chief Scientific Officer
November 2019
PathAI raises a $15,000,000 series B round from Bristol-Myers Squibb and Merck.
March 13, 2019
PathAI announced certification for a quality management system that complies with ISO 13485 and MDSAP.
January 2017
PathAI raises a $75,000,000 series B round from Bristol-Myers Squibb and Merck Global Health Innovation Fund.
December 2016
PathAI raises a $75,000,000 series B round from Bristol-Myers Squibb and Merck Global Health Innovation Fund.

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
PathAI Series B round December 2016
75,000,000
December 2016
3 Results
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Aditya Khosla

Co-Founder & CTO

Amaro Taylor-Weiner

Director of Biomedical Data Sciences

Arti Chhajta

Director of Product

Esther Ables

VP of Clinical & Regulatory Affairs

Micheal C. Montalto

Cheif Scientific Officer

Tiffany Freitas

Cheif Business Officer

Further reading

Title
Author
Link
Type
Date

Artificial intelligence decodes cancer pathology images

Elizabeth Dougherty

Web

November 12, 2018

Medicine Gets Digital: How Data Is Pushing Healthcare Forward

Emily Inverso

Web

October 2, 2017

PathAI - Paving the Road to Better Pathology

Alexander Culafi

Web

December 10, 2017

PathAI Demonstrates the Potential of AI-based Characterization of the Tumor Microenvironment at ASCO

AIT News Desk

Web

June 1, 2020

PathAI raises $60 million for AI pathology and diagnostic tools

Kyle Wiggers

Web

April 17, 2019

PathAI's $15M from Merck, BMS caps off its $75M Series B

Dave Muoio

Web

November 6, 2019

Documentaries, videos and podcasts

Title
Date
Link

AI's expanding role in modern medicine

May 11, 2017

Artificial intelligence for pathology

June 19, 2019

Philips and PathAI to improve breast cancer diagnosis with artificial intelligence

March 29, 2017

What if everyone in the world had access to the right diagnosis and roadmap to cure their disease?

n/a

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Jonathan Shieber
April 18, 2019
TechCrunch
With a clinical version of PathAI's computer vision-based pathogen detection service still at least one year from coming to market, the diagnostic technology developer has snagged $60 million in its latest round of financing. The company's tech is used by doctors to analyze cell samples...

References

Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.